| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 10/26/2004 | US6809093 Drug resistance therapy |
| 10/21/2004 | WO2004089942A2 Benzimidazolidinone derivatives as muscarinic agents |
| 10/21/2004 | WO2004089941A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 10/21/2004 | WO2004089937A1 7-membered heterocyclic derivative |
| 10/21/2004 | WO2004089927A1 Novel methods for the treatment of inflammatory diseases |
| 10/21/2004 | WO2004089918A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | WO2004089880A2 Carbamates useful as fragances |
| 10/21/2004 | WO2004089366A1 Bicyclic compounds as nr2b receptor antagonists |
| 10/21/2004 | WO2004069832A3 Antibacterial agents |
| 10/21/2004 | US20040210089 Reacting n-protected-3-oxazolidin-5-one derivative with halomethyl lithium; decyclizing and reducing; economic, efficient, industrial scale |
| 10/21/2004 | US20040209936 Compounds that modulate PPAR activity and methods of preparation |
| 10/21/2004 | US20040209932 1,3-substitued cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals |
| 10/21/2004 | US20040209931 Process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives |
| 10/21/2004 | US20040209928 saturated 5-member heterocyclyl-substituted (hetero)aroylaminoalkyl compounds, e.g., N-(4-{3-(4-tert-butylcyclohexyl)-2-oxo-1-[4-(trifluoromethoxy)phenyl]imidazolidin-4-yl}benzoyl)-beta-alanine and N-(4-{3-(4-tert-butylphenyl)-2-oxo-1-[4-(trifluoromethoxy)phenyl]imidazolidin-4-yl}benzoyl)-beta-alanine. |
| 10/21/2004 | US20040209920 Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 10/21/2004 | US20040209877 including benzoxazolinones, phenyl hydroxyamic acids, lactams obtainable from monocotyledonous plants or by chemical synthesis |
| 10/21/2004 | DE10313228A1 Synthese von 2-Chlormethyl-6-methylbenzoesäureestern Methylbenzoesäureestern 2-chloromethyl-6-Synthesis of |
| 10/21/2004 | CA2521907A1 Bicyclic compounds as nr2b receptor antagonists |
| 10/21/2004 | CA2521830A1 Heteroaromatic pentacyclic compound and medicinal use thereof |
| 10/21/2004 | CA2521606A1 Novel methods for the treatment of inflammatory diseases |
| 10/21/2004 | CA2519157A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 10/20/2004 | EP1468990A1 Piperazine derivative |
| 10/20/2004 | EP1467981A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| 10/20/2004 | EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b |
| 10/20/2004 | CN1171872C Compounds for modulation of PPAP gamma activity |
| 10/19/2004 | US6806384 Production method of β-amino-α-hydroxycarboxylic acid |
| 10/14/2004 | WO2004087697A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 10/14/2004 | WO2004087641A1 Hydrazone derivative |
| 10/14/2004 | WO2004087057A2 Methods for inhibition of angiogenesis |
| 10/14/2004 | WO2004071448A3 Substituted azole derivatives as inhibitors of protein tyrosine phosphatases |
| 10/14/2004 | WO2004004655A3 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 10/14/2004 | US20040204463 Aantimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium |
| 10/14/2004 | US20040204462 E.g., l2-{3-[2-(4-Fluorophenyl)oxazol-4-ylmethoxy]cyclohexyloxy}-6-methylbenzoic acid; lipid- and/or triglyceride-lowering properties; metabolic disorders; antidiabetic agents (type II); therapy of syndrome X; eating disorders; cardiomyopathy |
| 10/14/2004 | US20040204409 Useful as antagonists of NMDA (N-methyl-D-aspartate) NR2B receptor; for therapy of pain, stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, depression, anxiety, migraine |
| 10/14/2004 | CA2521056A1 Hydrazone derivative |
| 10/14/2004 | CA2520723A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 10/13/2004 | EP1466909A1 Halogenobenzyl aminopropionic acid derivatives |
| 10/13/2004 | EP1466898A1 Beta-amyloid protein production/secretion inhibitors |
| 10/13/2004 | EP1466891A1 Carboxylic acid derivative |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| 10/13/2004 | EP1213284B1 Processes for the preparation of oxo-oxazoline or alloamino acid derivatives |
| 10/13/2004 | EP1169038A4 Cyclic protein tyrosine kinase inhibitors |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/13/2004 | CN1170584C Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 10/12/2004 | US6803381 Carbamic acid derivatives |
| 10/07/2004 | WO2004085414A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 10/07/2004 | WO2004085388A2 Cyclic protein tyrosine kinase inhibitors |
| 10/07/2004 | WO2004085377A1 Synthesis of 2-chloromethyl-6-methylbenzoic acid esters |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198823 Process for preparing a creatine heterocyclic acid salt and method of use. |
| 10/07/2004 | US20040198786 Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198768 Method for inhibiting 5-lipoxygenase using a benzoxazole derivative or an analogue thereof |
| 10/07/2004 | US20040198716 Cysteine protease inhimbitors |
| 10/07/2004 | US20040197879 1,2,3,4-tetrazol-1-yl-L-alanine or 1,2,3,4-tetrazol-2-yl-L-alanine. |
| 10/07/2004 | CA2520055A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 10/07/2004 | CA2519715A1 Synthesis of 2-chloromethyl-6-methylbenzoic acid esters |
| 10/06/2004 | EP1463715A1 Novel glucagon antagonists |
| 10/06/2004 | EP1463714A2 Vanilloid receptor ligands and their use in treatments |
| 10/06/2004 | EP1463713A1 Prodrugs of excitatory amino acids |
| 10/06/2004 | EP1463502A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 10/06/2004 | EP1169312B1 Glucokinase activators |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | EP1080082B1 Intermediates for the synthesis of epothilones and methods for their preparation |
| 10/06/2004 | CN1535267A 5-membered heterocycles, preparation and use thereof as medicine |
| 10/06/2004 | CN1534379A Photosensitive composition and new compound therefor |
| 10/06/2004 | CN1534028A New azadicyclo salt kind compound and its use in treating protein aging disease |
| 10/06/2004 | CN1534027A New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease |
| 10/06/2004 | CN1534021A Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 10/05/2004 | US6800764 Process for the synthesis of chirally pure beta-amino-alcohols |
| 10/05/2004 | US6800486 Comprises reacting an amino acid or peptide with 2-chlorobenzoxazole; ultra-violet or fluorescent detection |
| 09/30/2004 | WO2004083170A2 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192956 By chlorination of the dimethylbenzoic ester; storage stable intermediate in synthesis of Peroxisome Proliferator Activated Receptor agonists by reaction with a 3-(2-phenyloxazol-4-ylmethoxy)propan-1-ol |
| 09/30/2004 | US20040192894 Compositions and methods related to fatty amino acid derivatives |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 09/30/2004 | US20040192702 Heteroaryl alkyl piperazine derivatives |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | US20040192669 Administering phenolic derivatives including 6-methoxy-2,3-benzoxazolinone (6-MBOA), benzoxazinoids-cyclic hydroxyamic acids, lactams, and corresponding glucosides; antiarthritic, antidiabetic, and hypoglycemic agents; sleep disorders, fibromyalgia; monocotyledon plant extracts |
| 09/30/2004 | US20040191679 Photosensitive composition and novel compound used therefor |
| 09/30/2004 | CA2518707A1 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/29/2004 | EP1461326A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 09/29/2004 | EP1461303A2 PROCESS FOR THE SYNTHESIS OF CHIRALLY PURE b-AMINO-ALCOHOLS |
| 09/29/2004 | EP1192162B1 Taxane derivatives and processes for the preparation thereof |
| 09/29/2004 | EP0912533B1 Alkylaminobenzothiazole and -benzoxazole derivatives |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1532535A Method for detecting compound having manoamine oxidase inhibiting activity |
| 09/29/2004 | CN1168707C 4-guanidinobenzamides antifertility compounds |
| 09/29/2004 | CN1168447C Use of oxazolidinones for preparation of medicament for transdermal delivery |
| 09/28/2004 | US6797717 Acyl coenzyme a cholesterol acyltransferase (acat) inhibitors |
| 09/23/2004 | WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same |
| 09/23/2004 | US20040186154 treating or preventing a hypercholesterolemia-related or an inflammation-related condition ; apical sodium co-dependent bile acid transport inhibitor and an amount of a cyclooxygenase-2 (COX-2) selective inhibitor or its prodrug; kits |
| 09/23/2004 | US20040186151 E.g., 2-[3-(4'-Methoxyphenyl)-propionylamino]-2-(4'-n-butoxy-3'-carboxyphenyl)-2-ethyl[4-(4'-nitrophenyl)]imidazole; inhibitors of protein tyrosine phosphatases; antidiabetic, -carcinogenic, -inflammation agents; antiallergens; infections; modulation of growth hormones/factors; Alzeimer's; obesity |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |